Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kalvin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
MMW, Munchener Medizinische Wochenschrift|January 23, 1976
[Double pylorus (author's transl)]L Domján, F Schneider, M Kalvin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
DNA breakage activity of the methanol extract of auromomycinD M Kalvin, C H Huang, M A Lischwe, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonistsWilliam A Carroll, Douglas M Kalvin, Arturo Perez Medrano, et al.
Journal of Medicinal Chemistry|April 29, 2008
Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonistsDerek W Nelson, Kathy Sarris, Douglas M Kalvin, et al.
Journal of Medicinal Chemistry|December 2, 1999
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activityK J Henry, J Wasicak, A S Tasker, et al.
Journal of Medicinal Chemistry|April 15, 2005
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activitiesFortuna Haviv, Michael F Bradley, Douglas M Kalvin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
MMW, Munchener Medizinische Wochenschrift|January 23, 1976
[Double pylorus (author's transl)]L Domján, F Schneider, M Kalvin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
DNA breakage activity of the methanol extract of auromomycinD M Kalvin, C H Huang, M A Lischwe, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonistsWilliam A Carroll, Douglas M Kalvin, Arturo Perez Medrano, et al.
Journal of Medicinal Chemistry|April 29, 2008
Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonistsDerek W Nelson, Kathy Sarris, Douglas M Kalvin, et al.
Journal of Medicinal Chemistry|December 2, 1999
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activityK J Henry, J Wasicak, A S Tasker, et al.
Journal of Medicinal Chemistry|April 15, 2005
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activitiesFortuna Haviv, Michael F Bradley, Douglas M Kalvin, et al.
Pageof 1